Few nonsurgical options are available for reducing pain and maintaining mobility of patients with hip osteoarthritis (OA). Intra-articular injections of corticosteroids or hyaluronic acid have shown ...

Please provide your email address to receive an email when new articles are posted on . Musa Zaid, MD, and colleagues from the department of orthopedic surgery at the University of California, San ...

An open-label, pilot study has demonstrated that intra-articular injections of hylan G-F 20—a cross-linked, high-molecular-weight derivative of hyaluronan—could potentially be an effective treatment ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients who received multiple intra-articular steroid hip injections prior to total hip ...

BOSTON - Hip and knee intra-articular corticosteroid injections, which are quite commonly given to treat joint pain, may be more harmful than medical professionals previously thought, according to new ...

OAK BROOK, Ill. - Corticosteroid injections used to treat osteoarthritis pain in the hip and knee may be more dangerous than previously thought, according to a special report published in the journal ...

A new study reveals that commonly given hip and knee steroid intra-articular injections may be harmful in some patients with at-risk conditions or may cause complications that are not well understood.

Commonly given hip and knee steroid intra-articular injections may be harmful to some patients with at-risk conditions, according to a new study. Corticosteroid injections are often given to reduce ...

A re-evaluation was undertaken in the Arthritis Clinic of the Philadelphia General Hospital to compare results with those obtained by other investigators. Included in this study are a number of cases ...

A single ultrasound-guided intra-articular hip injection of corticosteroid plus local anaesthetic can provide lasting pain relief in hip osteoarthritis, according to a new study led by researchers ...

BRIDGEWATER, N.J., March 30, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company focused on developing proprietary, innovative, and ...